GGrantIndex
← Leaderboards

Richard A Lang

Cincinnati Childrens Hosp Med Ctr

$20,891,019
Attributed
$25,445,838
Total exposure
16
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.3M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$25,445,838 · 16

By mechanism

R01$24,588,213 · 14
R03$447,000 · 1
R21$410,625 · 1

Top collaborators

Others in their field

Top investigators on “Pathway Interactions

Research focus

Pathway InteractionsRetinaResponseSignal TransductionVisionRegulationMediatingGeneticCellsBlood VesselsEye DevelopmentBiologyLightLensDesignRetinopathy Of PrematurityLoss Of FunctionLaboratory MouseRetinalPublishingProductionBaseMelanopsinInterest

Grant awards (71)

Melanopsin-dependent light-evoked development of rod photoreceptors$341,063
R01 · FY2025 · EY · contact PI
Light regulated vascular development in the eye via the Hippo pathway$432,345
R01 · FY2024 · EY · contact PI
Melanopsin-dependent light-evoked development of rod photoreceptors$401,250
R01 · FY2024 · EY · contact PI
Mechanisms of intrinsic light responses in the ocular lens$382,724
R01 · FY2024 · EY · contact PI
Light regulated vascular development in the eye via the Hippo pathway$432,345
R01 · FY2023 · EY · contact PI
Melanopsin-dependent light-evoked development of rod photoreceptors$401,250
R01 · FY2023 · EY · contact PI
Mechanisms of intrinsic light responses in the ocular lens$381,754
R01 · FY2023 · EY · contact PI
Light regulated vascular development in the eye via the Hippo pathway$419,373
R01 · FY2022 · EY · contact PI
Mechanisms of intrinsic light responses in the ocular lens$371,242
R01 · FY2022 · EY · contact PI
Mechanisms of intrinsic light responses in the ocular lens$424,751
R01 · FY2021 · EY · contact PI
Light regulated vascular development in the eye via the Hippo pathway$346,787
R01 · FY2021 · EY · contact PI
Regulation of vascular development in the eye by an opsin 5-dependent clock$478,648
R01 · FY2020 · EY · contact PI
Regulation of eye development by an Opsin5-dopamine pathway$463,580
R01 · FY2020 · EY
Regulation of vascular development in the eye by an opsin 5-dependent clock$478,648
R01 · FY2019 · EY · contact PI
Regulation of eye development by an Opsin5-dopamine pathway$459,814
R01 · FY2019 · EY
Regulation of vascular development in the eye by an opsin 5-dependent clock$478,648
R01 · FY2018 · EY · contact PI
Regulation of eye development by an Opsin5-dopamine pathway$475,414
R01 · FY2018 · EY
Regulation of eye development by an Opsin5-dopamine pathway$489,414
R01 · FY2017 · EY
Regulation of vascular development in the eye by an opsin 5-dependent clock$478,648
R01 · FY2017 · EY · contact PI
Regulation of vascular development in the eye by an opsin 5-dependent clock$494,153
R01 · FY2016 · EY · contact PI
Light regulated vascular development of the eye$456,523
R01 · FY2016 · EY · contact PI
Retinal Microglia and Angiogenesis$382,500
R01 · FY2016 · EY · contact PI
Light regulated vascular development of the eye$450,939
R01 · FY2015 · EY · contact PI
Retinal Microglia and Angiogenesis$374,850
R01 · FY2015 · EY · contact PI
Light regulated vascular development of the eye$544,613
R01 · FY2014 · EY · contact PI
Retinal Microglia and Angiogenesis$374,850
R01 · FY2014 · EY · contact PI
Wnt Pathway Regulation of Lens Polarity$374,850
R01 · FY2014 · EY · contact PI
Light regulated vascular development of the eye$477,875
R01 · FY2013 · EY · contact PI
Retinal Microglia and Angiogenesis$363,375
R01 · FY2013 · EY · contact PI
Wnt Pathway Regulation of Lens Polarity$363,375
R01 · FY2013 · EY · contact PI
Light regulated vascular development of the eye$92,801
R01 · FY2013 · EY · contact PI
Retinal Microglia and Angiogenesis$382,500
R01 · FY2012 · EY · contact PI
Wnt Pathway Regulation of Lens Polarity$382,500
R01 · FY2012 · EY · contact PI
Wnt Pathway Regulation of Lens Polarity$382,084
R01 · FY2011 · EY · contact PI
RhoGTPases in Early Eye Development$320,760
R01 · FY2011 · EY · contact PI
CRIM1-b-Catenin-Cadherin Interactions in Eye Development and Disease$373,445
R01 · FY2010 · EY · contact PI
RhoGTPases in Early Eye Development$334,125
R01 · FY2010 · EY · contact PI
Eyes Absent phosphatase inhibitors in eye disease$185,625
R21 · FY2010 · EY
CRIM1-b-Catenin-Cadherin Interactions in Eye Development and Disease$375,000
R01 · FY2009 · EY · contact PI
Developing vision: Cadherin function in lens morphogenesis$364,137
R01 · FY2009 · EY · contact PI
RhoGTPases in Early Eye Development$337,500
R01 · FY2009 · EY · contact PI
Eyes Absent phosphatase inhibitors in eye disease$225,000
R21 · FY2009 · EY
Developing vision: Cadherin function in lens morphogenesis$356,855
R01 · FY2008 · EY · contact PI
Developing vision: Wnts in programmed vessel regression$354,475
R01 · FY2008 · EY · contact PI
RhoGTPases in Early Eye Development$294,000
R01 · FY2008 · EY · contact PI
Developing vision: Cadherin function in lens morphogenesis$364,137
R01 · FY2007 · EY · contact PI
Developing vision: Wnts in programmed vessel regression$361,709
R01 · FY2007 · EY · contact PI
RhoGTPases in Early Eye Development$300,000
R01 · FY2007 · EY · contact PI
Developing vision: Cadherin function in lens morphogenesis$366,188
R01 · FY2006 · EY · contact PI
Developing vision: Wnts in programmed vessel regression$363,746
R01 · FY2006 · EY · contact PI
Developing vision: Cadherin function in lens morphogenesis$373,959
R01 · FY2005 · EY
Developing vision: Wnts in programmed vessel regression$372,500
R01 · FY2005 · EY
Molecular Regulation of Lacrimal Gland Branching$333,000
R01 · FY2005 · EY
A Cell-Based Therapy for Cataracts$149,000
R03 · FY2005 · EY
Developing vision: Wnts in programmed vessel regression$372,500
R01 · FY2004 · EY
THE MECHANISM OF LENS AND LACRIMAL GLAND DEVELOPMENT$370,000
R01 · FY2004 · EY
Molecular Regulation of Lacrimal Gland Branching$296,000
R01 · FY2004 · EY
A Cell-Based Therapy for Cataracts$149,000
R03 · FY2004 · EY
THE MECHANISM OF LENS AND LACRIMAL GLAND DEVELOPMENT$370,000
R01 · FY2003 · EY
DEVELOPING VISION--THE MECHANISM OF TISSUE REMODELING$335,867
R01 · FY2003 · EY
Molecular Regulation of Lacrimal Gland Branching$296,000
R01 · FY2003 · EY
A Cell-Based Therapy for Cataracts$149,000
R03 · FY2003 · EY
THE MECHANISM OF LENS AND LACRIMAL GLAND DEVELOPMENT$333,000
R01 · FY2002 · EY
DEVELOPING VISION--THE MECHANISM OF TISSUE REMODELING$326,084
R01 · FY2002 · EY
Molecular Regulation of Lacrimal Gland Branching$296,000
R01 · FY2002 · EY
THE MECHANISM OF LENS AND LACRIMAL GLAND DEVELOPMENT$368,720
R01 · FY2001 · EY
Molecular Regulation of Lacrimal Gland Branching$296,000
R01 · FY2001 · EY
DEVELOPING VISION--THE MECHANISM OF TISSUE REMODELING$218,405
R01 · FY2001 · EY
DEVELOPING VISION--THE MECHANISM OF TISSUE REMODELING$134,545
R01 · FY2001 · EY
DEVELOPING VISION--THE MECHANISM OF TISSUE REMODELING$342,669
R01 · FY2000 · EY
DEVELOPING VISION--GROWTH FACTORS IN LENS MORPHOGENESIS$251,401
R01 · FY2000 · EY